Hope for Inflammatory Bowel Disease Treatment with 'Mini Guts'
Topic: Medical Research
Ronan Somers has ulcerative colitis, a type of inflammatory bowel disease.
In short:
Researchers at Monash University are closer to understanding inflammatory bowel disease.
Inflammatory bowel disease includes chronic conditions like Crohn's and ulcerative colitis.
Scientists have made tiny 3D models of intestinal lining from pediatric IBD patients.
Ronan Somers is a 12-year-old boy with a hidden illness.
His ulcerative colitis has stopped him from doing things he loves.
He said, 'I couldn't do a lot of stuff because I felt very tired.'
Ronan's stomach hurt, and he went to the toilet six times a day.
Ulcerative colitis is a type of inflammatory bowel disease.
It causes inflammation and ulcers in the large intestine.
There is no cure, but it can be managed with medication.
Ronan says IBD has stopped him from doing things a 12-year-old would do.
He has missed one in five days at school due to illness.
The road to diagnosis and treatment was long and difficult.
Ronan's mother said it took 904 days to find the right treatment.
He tried many medications that didn't work.
Researchers created 'mini guts'
Ronan's journey to remission is common, but scientists want to change this.
They made tiny 3D models of intestinal lining from pediatric IBD patients.
These 'mini guts' are a game-changing research tool.
They allow scientists to study the disease in living tissue.
Professor Helen Abud says the 'mini guts' are a game-changer.
Scientists can inject gut bacteria into the patients' organoid models.
This helps researchers understand the interaction between bacteria and the bowel lining.
3D models help scientists study the disease and develop new therapies.
The hope is that this will lead to more precise and tailored treatments.
Researchers are starting to understand the complexity of the disease.
They want to target the right treatment to the right patient.
Edward Giles co-authored the research paper.
The team created a 'living bio bank' of organoids from different patients.
The goal is to find the best treatment for each individual patient.
The patient population is from local pediatric Australian patients.
IBD prevalence is growing
Professor Paul Pavli described the research as 'exciting'.
He said it's a very important study that will provide valuable insight.
The research will help understand how normal bacteria cause abnormalities.
This will enable medical professionals to understand the basic mechanisms of the disease.
It could lead to personalized medical care.
This is leading towards personalized medicine.
It's not something that will develop in the next few years.
IBD affects about 180,000 Australians, and the number is rising.
By 2030, 1% of the population will have IBD.
The statistics are alarming for advocates like Leanne Raven.
Leanne Raven says IBD has the least investment in research.
The prevalence and incidence of IBD are compounding.
There are many barriers to diagnosis and remission.
A recent study found IBD has the lowest investment in research.
Being able to use technology to test different things is fantastic.
Research is the hope for the future.
Dr. Pavli agreed, but said the field doesn't receive much funding.
Crohn's and colitis are not 'sexy' diseases.
They're not well-known, so there's not much public awareness.
These conditions are serious and affect young people significantly.
Anything that provides insight will lead to better treatments.
See more ABC coverage
Promotion
Top Stories
Topic: Earthquakes
Topic: War
Topic: World Politics
Topic: Aged Care
Topic: World Politics
Related stories
Topic: Health
Topic: Public Health
Related topics
Health
Irritable Bowel Syndrome
Medical Research
Melbourne
Top Stories
Topic: Earthquakes
Topic: War
Topic: World Politics
Topic: Aged Care
Topic: World Politics
Just In
LIVE
Topic: Food and Drink
Topic: Crime
Topic: Feel Good